Interestingly, the intricate relationship between EP300 and FOXA1 is evident in PCa patients, where a strong positive correlation is observed between the expression levels of FOXA1 and EP300/CREBBP (Supplementary Fig. S9f), particularly in primary and AR-positive CRPC patients. Here, FOXA1 is linked to posterior cortical atrophy.